What is Bezlotoxumab: Uses, Dosage, Side Effects and More

Bezlotoxumab is a specialized antibody medication designed to prevent a dangerous intestinal infection from coming back. If you've been dealing with Clostridioides difficile (C. diff) infections, your doctor might recommend this treatment to help protect you from future episodes.

This medication works differently from typical antibiotics. Instead of killing bacteria directly, it helps your immune system recognize and fight off the toxins that make C. diff infections so harmful. Think of it as giving your body's natural defenses a helpful boost when they need it most.

What is Bezlotoxumab?

Bezlotoxumab is a monoclonal antibody that targets toxin B produced by Clostridioides difficile bacteria. This prescription medication comes as an intravenous infusion, meaning it's given directly into your bloodstream through a vein.

The medication belongs to a class of drugs called monoclonal antibodies. These are laboratory-made proteins that mimic your immune system's ability to fight harmful substances. Bezlotoxumab specifically binds to and neutralizes the toxin that causes the most severe symptoms of C. diff infections.

Unlike antibiotics that kill bacteria, bezlotoxumab works by blocking the harmful effects of bacterial toxins. This approach helps reduce the risk of recurring infections while allowing your normal gut bacteria to recover more effectively.

What is Bezlotoxumab Used For?

Bezlotoxumab is used to reduce the likelihood of Clostridioides difficile infection recurrence in adults who are at high risk for coming back. Your doctor will typically recommend this medication if you're currently receiving antibiotic treatment for C. diff and have certain risk factors.

This medication is particularly helpful for people who have had multiple C. diff infections before. Studies show that about 20-30% of people who recover from one C. diff infection will develop another one within a few months. Bezlotoxumab can significantly lower this risk.

The medication is also considered for patients who are over 65 years old, have compromised immune systems, or have severe underlying health conditions. These factors make it more likely that C. diff infections will return and potentially become more serious.

How Does Bezlotoxumab Work?

Bezlotoxumab works by targeting and neutralizing toxin B, one of the main harmful substances produced by C. diff bacteria. This toxin is responsible for the inflammation and damage that occurs in your intestines during an infection.

When you receive bezlotoxumab, these specialized antibodies circulate in your bloodstream and bind to toxin B molecules. By attaching to the toxin, the antibodies prevent it from damaging your intestinal cells and causing the symptoms associated with C. diff infections.

This is considered a moderately strong preventive treatment. While it doesn't directly kill the bacteria, it provides substantial protection against the toxins that cause the most harm. The effects can last for several months, giving your body time to restore healthy gut bacteria balance.

How Should I Take Bezlotoxumab?

Bezlotoxumab is given as a single intravenous infusion in a healthcare setting like a hospital or infusion center. The medication is mixed with saline solution and administered slowly over about 60 minutes through an IV line in your arm.

You don't need to fast before receiving bezlotoxumab, and there are no specific dietary restrictions. However, it's helpful to eat a light meal beforehand to prevent any potential nausea during the infusion. Staying well-hydrated by drinking plenty of water is also recommended.

The infusion will be given while you're still taking antibiotics for your current C. diff infection. Your healthcare team will monitor you closely during and after the treatment to watch for any reactions. Most people can go home the same day after a brief observation period.

How Long Should I Take Bezlotoxumab For?

Bezlotoxumab is given as a one-time treatment, not as an ongoing medication. You'll receive a single infusion that provides protection for several months following your current C. diff infection treatment.

The protective effects typically last for about 12 weeks after the infusion. During this time, the antibodies remain active in your system, helping to prevent toxin B from causing another infection if you're exposed to C. diff bacteria again.

Your doctor will monitor your recovery and may recommend additional preventive measures beyond the 12-week period. However, most people don't need repeated doses of bezlotoxumab unless they develop another C. diff infection in the future.

What Are the Side Effects of Bezlotoxumab?

Most people tolerate bezlotoxumab well, but like any medication, it can cause side effects. The most common reactions are generally mild and occur during or shortly after the infusion.

Here are the side effects you might experience, keeping in mind that many people have no problems at all:

• Nausea and fatigue - These are the most frequently reported side effects, affecting about 7-8% of patients
• Fever and headache - May occur during or within a few hours of the infusion
• Dizziness - Usually mild and temporary
• Injection site reactions - Redness, swelling, or discomfort where the IV was placed

More serious but rare side effects can include heart problems, particularly if you already have heart disease. Your healthcare team will monitor your heart rate and blood pressure during the infusion to catch any concerning changes early.

Allergic reactions to bezlotoxumab are uncommon but possible. Signs might include difficulty breathing, swelling of the face or throat, or severe skin reactions. This is why you'll be closely monitored during and after your treatment.

Who Should Not Take Bezlotoxumab?

Bezlotoxumab isn't suitable for everyone, and your doctor will carefully review your medical history before recommending this treatment. The medication is not approved for use in children under 18 years old.

People with certain heart conditions may need special consideration or might not be candidates for this treatment. If you have congestive heart failure or a history of serious heart rhythm problems, your doctor will weigh the benefits against potential risks very carefully.

You should tell your doctor about any previous allergic reactions to medications, especially other monoclonal antibodies. While rare, some people may be allergic to components in bezlotoxumab, making treatment unsafe.

Pregnant or breastfeeding women should discuss the risks and benefits with their healthcare provider. While there's limited data on bezlotoxumab use during pregnancy, your doctor can help determine if the benefits outweigh any potential risks for you and your baby.

Bezlotoxumab Brand Name

Bezlotoxumab is available under the brand name Zinplava. This is the only brand name currently available for this medication in the United States and many other countries.

Zinplava is manufactured by Merck and was approved by the FDA in 2016. There are currently no generic versions of bezlotoxumab available, so Zinplava is the only option if your doctor prescribes this treatment.

Your insurance coverage may vary for brand-name medications like Zinplava. It's worth checking with your insurance provider about coverage and any prior authorization requirements before scheduling your treatment.

Bezlotoxumab Alternatives

While bezlotoxumab is unique in its approach to preventing C. diff recurrence, there are other strategies your doctor might consider. These alternatives work differently but can also help reduce the risk of recurring infections.

Fecal microbiota transplantation (FMT) is another option for preventing C. diff recurrence. This procedure involves introducing healthy gut bacteria from a donor to help restore your natural intestinal balance. FMT can be highly effective but requires specialized facilities and careful screening.

Extended or tapered antibiotic courses might be recommended instead of or alongside bezlotoxumab. Some doctors prescribe vancomycin or fidaxomicin for longer periods or in gradually decreasing doses to prevent recurrence.

Probiotics and dietary modifications can also play a supportive role, though they're typically used alongside other treatments rather than as standalone alternatives. Your doctor will help determine the best approach based on your specific situation and risk factors.

Is Bezlotoxumab Better Than Vancomycin?

Bezlotoxumab and vancomycin work in completely different ways, so comparing them directly isn't quite like comparing apples to apples. Vancomycin is an antibiotic that treats active C. diff infections, while bezlotoxumab prevents future infections from recurring.

Most people who receive bezlotoxumab are also taking vancomycin or another antibiotic to treat their current infection. The two medications work together rather than competing with each other. Vancomycin kills the C. diff bacteria causing your current symptoms, while bezlotoxumab helps prevent future episodes.

Studies show that people who receive bezlotoxumab along with standard antibiotic treatment have about a 10% lower risk of recurrent C. diff infections compared to those who receive antibiotics alone. This makes bezlotoxumab a valuable addition to treatment rather than a replacement for antibiotics.

Your doctor will consider factors like your age, previous C. diff infections, and overall health when deciding whether to recommend bezlotoxumab alongside your antibiotic treatment. The combination approach often provides the best protection against both current and future infections.